Erschienen in:
01.02.2011 | Case Report
Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia
verfasst von:
T. Bauters, V. Mondelaers, H. Robays, H. De Wilde, Y. Benoit, B. De Moerloose
Erschienen in:
International Journal of Clinical Pharmacy
|
Ausgabe 1/2011
Einloggen, um Zugang zu erhalten
Abstract
Case We report a case of simultaneous methemoglobinemia and hemolytic anemia, probably related to the use of rasburicase, in a child starting treatment for acute lymphoblastic leukemia (ALL). In addition, the patient developed symptoms of pancreatitis. All complications resolved after 3 days of supportive therapy. Conclusion Although usually well tolerated in pediatrics, physicians prescribing rasburicase should be aware of these possible life-threatening adverse reactions.